Literature DB >> 12807943

Chapter 5: Viral and host factors in human papillomavirus persistence and progression.

Sophia S Wang1, Allan Hildesheim.   

Abstract

Understanding the interdependent roles that host and viral factors play in cervical cancer pathogenesis is important for distinguishing women at the highest risk of human papillomavirus (HPV) persistence and progression to cervical cancer. Ongoing research on viral factors such as viral variants is providing important clues regarding HPV oncogenesis; the comprehensive characterization of the HPV genome and the function of viral genes by HPV type and variant will further this understanding. Although the biologic importance of viral integration and viral load measurements in cervical neoplasia is still being debated, available data are difficult to interpret because of methodologic limitations; to sufficiently address the importance of these events will require further methods validation and subsequent application in epidemiologic studies. Continued and expanded investigation of host immune responses-humoral, cellular, and innate immunity-should specifically address the outcomes of HPV persistence and progression to cervical cancer. Molecularly based assays paired with functional assays will be integral toward the identification and validation of key immune pathways and genes specifically relevant to cervical cancer pathogenesis. Novel technologies such as gene expression microarrays will further allow comprehensive identification of relevant genes that are important at various stages of cervical pathogenesis. The study of viral and host factors will undoubtedly lead to markers that may hold diagnostic and/or prognostic value; the clinical validity and utility of these molecular events will, therefore, need to be carefully assessed before implementation in a population setting.

Entities:  

Mesh:

Year:  2003        PMID: 12807943     DOI: 10.1093/oxfordjournals.jncimonographs.a003480

Source DB:  PubMed          Journal:  J Natl Cancer Inst Monogr        ISSN: 1052-6773


  42 in total

1.  HPV16 viral load and physical state measurement as a potential immediate triage strategy for HR-HPV-infected women: a study in 644 women with single HPV16 infections.

Authors:  Anna Manawapat-Klopfer; Lisa Wang; Juliane Haedicke-Jarboui; Frank Stubenrauch; Christian Munk; Louise T Thomsen; Peter Martus; Susanne K Kjaer; Thomas Iftner
Journal:  Am J Cancer Res       Date:  2018-04-01       Impact factor: 6.166

2.  A Retrospective 20-Year Analysis of Proliferative Verrucous Leukoplakia and Its Progression to Malignancy and Association with High-risk Human Papillomavirus.

Authors:  Jasbir D Upadhyaya; Sarah G Fitzpatrick; Mohammed N Islam; Indraneel Bhattacharyya; Donald M Cohen
Journal:  Head Neck Pathol       Date:  2018-02-09

3.  Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology.

Authors:  Sophia S Wang; Amr M Abdou; Lindsay M Morton; Rasmi Thomas; James R Cerhan; Xiaojiang Gao; Wendy Cozen; Nathaniel Rothman; Scott Davis; Richard K Severson; Leslie Bernstein; Patricia Hartge; Mary Carrington
Journal:  Blood       Date:  2010-04-12       Impact factor: 22.113

4.  CEACAM1 in cervical cancer and precursor lesions: association with human papillomavirus infection.

Authors:  Benibelks Albarran-Somoza; Ramon Franco-Topete; Vidal Delgado-Rizo; Felipe Cerda-Camacho; Lourdes Acosta-Jimenez; Miguel Lopez-Botet; Adrian Daneri-Navarro
Journal:  J Histochem Cytochem       Date:  2006-08-21       Impact factor: 2.479

5.  Quantitative human papillomavirus 16 and 18 levels in incident infections and cervical lesion development.

Authors:  Rachel L Winer; Tiffany G Harris; Long Fu Xi; Kathrin U Jansen; James P Hughes; Qinghua Feng; Carolee Welebob; Jesse Ho; Shu-Kuang Lee; Joseph J Carter; Denise A Galloway; Nancy B Kiviat; Laura A Koutsky
Journal:  J Med Virol       Date:  2009-04       Impact factor: 2.327

6.  Human papillomavirus (HPV) types 16, 18, 31, 45 DNA loads and HPV-16 integration in persistent and transient infections in young women.

Authors:  Agnihotram V Ramanakumar; Otelinda Goncalves; Harriet Richardson; Pierre Tellier; Alex Ferenczy; François Coutlée; Eduardo L Franco
Journal:  BMC Infect Dis       Date:  2010-11-11       Impact factor: 3.090

Review 7.  Human papillomavirus-mediated carcinogenesis and HPV-associated oral and oropharyngeal squamous cell carcinoma. Part 2: Human papillomavirus associated oral and oropharyngeal squamous cell carcinoma.

Authors:  Liviu Feller; Neil H Wood; Razia A G Khammissa; Johan Lemmer
Journal:  Head Face Med       Date:  2010-07-15       Impact factor: 2.151

8.  Racial differences in the incidence and clearance of human papilloma virus (HPV): the HPV in men (HIM) study.

Authors:  Matthew B Schabath; Luisa L Villa; Hui-Yi Lin; William J Fulp; Gabriel O Akogbe; Martha E Abrahamsen; Mary R Papenfuss; Eduardo Lazcano-Ponce; Jorge Salmerón; Manuel Quiterio; Anna R Giuliano
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-07-19       Impact factor: 4.254

9.  Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinants.

Authors:  Sophia S Wang; Rosemary E Zuna; Nicolas Wentzensen; S Terence Dunn; Mark E Sherman; Michael A Gold; Mark Schiffman; Sholom Wacholder; Richard A Allen; Ingrid Block; Kim Downing; Jose Jeronimo; J Daniel Carreon; Mahboobeh Safaeian; David Brown; Joan L Walker
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-01       Impact factor: 4.254

10.  Common genetic variants and risk for HPV persistence and progression to cervical cancer.

Authors:  Sophia S Wang; Paula Gonzalez; Kai Yu; Carolina Porras; Qizhai Li; Mahboobeh Safaeian; Ana Cecilia Rodriguez; Mark E Sherman; Concepcion Bratti; Mark Schiffman; Sholom Wacholder; Robert D Burk; Rolando Herrero; Stephen J Chanock; Allan Hildesheim
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.